Most GLP-1 pricing on the internet is a riddle: an advertised membership here, a "from" price there, and the real monthly number buried in a footnote. This page answers the question directly — but it answers it by explaining what actually sets your price, rather than quoting a number we have no ability to honour.

GoodLife Health does not sell medication. We take no pharmacy margin, no molecule upcharge, no dose upcharge, and no manufacturer rebate. Your prescription goes to the pharmacy you choose, and that pharmacy bills you directly at its own price. That is exactly why there is no price list on this page: we have no stake in what you pay and no say in it, so any figure we printed would be someone else's — quoted secondhand and out of date the moment it moved.

Key Takeaways
  • What you pay for a branded GLP-1 is set by your pharmacy and your coverage, not by your telehealth provider.
  • Four channels decide the number: manufacturer self-pay programs, your insurance benefit, retail and mail-order cash prices, and manufacturer savings cards.
  • All four move. Check them at the source before you start, and check again when you reach your maintenance dose.
  • Price the maintenance dose, not the starting dose — that is where a year of therapy actually lives.
  • The GoodLife Health membership is a flat $299/month for the clinical relationship and quarterly Biomarker Audits. It never changes with molecule or dose.

The four channels that set your price

What determines your GLP-1 cost

GoodLife Health earns nothing in any of these channels

ChannelWhat it isWhere to check your own price
Manufacturer self-payDirect-from-manufacturer pricing for people paying cashLillyDirect for Zepbound, Mounjaro and Foundayo; NovoCare for Wegovy and Ozempic
Your insurance benefitCoverage varies by plan, employer, and which label the drug carriesYour plan formulary or pharmacy benefit manager
Retail and mail-order pharmacyThe cash price at whichever pharmacy fills the scriptThe pharmacy itself — cash prices differ between pharmacies for the same dose
Manufacturer savings cardsCopay assistance, generally for commercially insured patientsThe manufacturer's site for your specific product

Those four channels are not ranked, because the ranking is personal. The cheapest lane for a 2.5mg starting dose is frequently not the cheapest lane at a 15mg maintenance dose, and a plan that covers a drug under one label may not cover it under another. The only reliable answer is the one you get by checking your own dose, in your own channel, before you commit.

For scale: U.S. list prices for injectable GLP-1s have been widely reported in the four-figure range per month, and every one of the channels above exists to sit below that. Manufacturer self-pay programs in particular have moved repeatedly since launch — which is the strongest argument there is for reading them at the source rather than trusting a number on a page like this one.

Why we will not quote you a medication price

This is a positioning statement with a mechanical basis. The $299 membership is the only revenue GoodLife Health earns from your care. There is no spread on the molecule, no margin that widens as your dose climbs, and no rebate arriving from a manufacturer behind the scenes. A platform that earns on the prescription has a reason to quote you a medication price: the number is theirs to set, and quoting it moves the sale.

We are indifferent to where you fill your prescription — genuinely indifferent, in the sense that nothing in our revenue changes based on your answer. That indifference is worth more to you than a quoted price would be, because it is the reason your clinician can tell you a cheaper channel exists without costing us anything to say so.

Price the maintenance dose, not the starting dose

GLP-1 dosing is designed to climb. You start low to build tolerance, and your clinician steps you up over months toward a maintenance dose. The evidence behind the destination is the strongest in obesity medicine: roughly 15% average body-weight loss on semaglutide 2.4mg over 68 weeks (STEP 1), and up to about 21% on tirzepatide over 72 weeks (SURMOUNT-1).

This matters for cost because the starting dose is the number platforms advertise and the maintenance dose is the number you live with. Before you begin, price your likely maintenance dose in whichever channel you plan to use — then compare that to the advertised entry price. The gap between those two figures is the single most common reason a GLP-1 budget breaks in month four. Where the gap is manufactured on purpose by the provider rather than the pharmacy, it has a name: the dose-escalation trap.

The GoodLife Health membership is deliberately immune to this. It is $299 at every rung of the ladder, because the clinical work of titrating you is the same work regardless of which rung you are on.

Why branded only

GoodLife Health prescribes branded, FDA-approved GLP-1 medications exclusively — never compounded semaglutide or tirzepatide, under any circumstance. Branded products carry FDA-reviewed manufacturing, tested dosing devices, and the clinical trial evidence behind every dose discussed here. The compounded market carries none of those guarantees and has been the subject of repeated FDA warnings. The platform is LegitScript certified.

This is also a pricing warning. A quoted price that undercuts the manufacturer's own self-pay channel is usually not the same molecule under the same oversight, and the difference is not a discount — it is a different product.

Zepbound and Mounjaro are the same molecule

Zepbound and Mounjaro are both tirzepatide, made by Eli Lilly, carrying different FDA labels: Mounjaro for type 2 diabetes, Zepbound for weight management. The label determines which one is clinically appropriate for you, and it also tends to move the price — the two products are commonly priced very differently in cash channels despite being the same active molecule.

Worth knowing before you shop, because it means a price comparison between them is not really a comparison of drugs. If your clinical picture could support either label, that is a conversation to have with your clinician, and then a price to check in your own channel for whichever one applies. A platform earning margin on the drug has little reason to volunteer any of this. A zero-markup platform has no reason not to.

What the membership covers, and what it does not

The membership covers the clinical work: comprehensive Biomarker Audits every 90 days, contraindication screening, dose titration, side-effect management, monthly check-ins, and hormone optimization when indicated. Flat $299 a month.

It does not cover the medication, and it never touches it. The pharmacy bills you at its own price. Those two numbers never blend, which is what keeps both of them honest — and it is why the clinical fee can be printed on a public page with total confidence while the medication price cannot.

GoodLife Health prescribes branded, FDA-approved GLP-1 medications only. It does not facilitate compounded semaglutide or tirzepatide under any circumstance.

The numbers we can actually stand behind
$299
Flat monthly membership, identical at every molecule and every dose
4
Biomarker Audits included per year, retail value $1,000 to $2,000
$0
Pharmacy margin, molecule upcharge, dose upcharge, and manufacturer rebate
15%–21%
Average body-weight loss in the pivotal semaglutide and tirzepatide trials

How to use this page when comparing platforms

  • Ask any competing platform for its price at your maintenance dose, not the starting dose. Then ask what happens to that price when you step up.
  • Ask whether the quoted price includes the clinical fee, and what the clinical fee includes. Here, $299 covers quarterly Biomarker Audits, monthly check-ins, and hormone optimization when indicated.
  • Ask whether the platform earns anything on the medication. The honest answer tells you whether its price is a report or a decision.
  • Ask whether you can take your prescription to a pharmacy of your choosing. If the answer is no, the price is not a market price.
  • Confirm branded versus compounded before you compare any two numbers at all.

FAQ

What does Wegovy cost without insurance? It depends on the channel you use and the dose you are on. Novo Nordisk publishes self-pay pricing through NovoCare, retail and mail-order pharmacies set their own cash prices, and savings cards may apply if you are commercially insured. Check your specific dose at the source. GoodLife Health takes no margin on it either way.

Why does this page not list medication prices? Because we do not set them and earn nothing from them. Your pharmacy bills you at its own price, and that price moves. A list here would be someone else's number quoted secondhand — accurate for as long as it happened to be, and misleading afterwards.

Why is Mounjaro often more expensive than Zepbound? They are the same molecule — tirzepatide — with different FDA labels. Mounjaro carries the type 2 diabetes label and Zepbound the weight-management label. The label drives both clinical appropriateness and, in most cash channels, a meaningfully different price.

Are there oral GLP-1 options? Yes — Wegovy Tablets (oral semaglutide) and Foundayo (orforglipron), both branded and FDA-approved. They are covered in detail in the oral GLP-1 guide.

Does the GoodLife Health fee change with my medication? Never. The membership is a flat $299/month regardless of molecule or dose. Medication is billed separately by whichever pharmacy you choose.

Will my price go up as my dose goes up? Your membership will not. Your medication price may, depending on the channel — which is why the maintenance dose is the figure worth pricing before you start, not the starting dose.

Can my insurance cover the medication? Where your plan covers it, the pharmacy bills your insurer and you pay whatever copay your plan sets. That is arranged between you, your pharmacy, and your insurer; GoodLife Health takes no share of it and the $299 membership does not change.

Can I use my own pharmacy? Yes. Your prescription goes wherever you want it to go, and you pay that pharmacy directly. We are indifferent to your choice, which is the entire point.

Related guides

References

  1. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1, NEJM). 2021. pubmed.ncbi.nlm.nih.gov/33567185/
  2. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM). 2022. pubmed.ncbi.nlm.nih.gov/35658024/